Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial

Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study

(2013) Xiao Liang et al.   Clinical Gastroenterology and Hepatology

Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy

(2013) Jingxian Liao et al.   HELICOBACTER

Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma

(2012) Zaiming Lu et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Guide Regarding Choice of Second-line Therapy to Obtain a High Cumulative Cure Rate

(2012) David Y. Graham et al.   HELICOBACTER

The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study

(2012) Seng-Kee Chuah et al.   HELICOBACTER

The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy

(2012) Francis Mégraud   Therapeutic Advances in Gastroenterology

Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection

(2011) Stephan Miehlke et al.   HELICOBACTER

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Optimal therapy for Helicobacter pylori infections

(2011) Emiko Rimbara et al.   Nature Reviews Gastroenterology & Hepatology

Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection

(2010) Takahisa Furuta et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China

(2010) Wen Gao et al.   HELICOBACTER

Resistance ofHelicobacter pylorito antibiotics from 2000 to 2009 in Shanghai

(2010) Qin-Juan Sun   WORLD JOURNAL OF GASTROENTEROLOGY